Welcome to our dedicated page for Precipio SEC filings (Ticker: PRPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Precipio, Inc. filings document the public-company disclosures of a specialty cancer diagnostics issuer with Pathology Services and Products operations. Its Form 8-K reports include Regulation FD updates for shareholder calls and investor presentations, furnished financial results, and material-event disclosures related to corporate communications and operating performance.
The company’s proxy materials describe annual meeting procedures, stockholder voting matters, governance, and access to annual reporting materials. Other filings document capital-structure matters, including common stock activity and the termination of an at-the-market sales agreement, alongside formal exhibits and disclosures tied to Precipio’s diagnostics business and shareholder communications.
Precipio, Inc. (PRPO) reported an insider transaction by a director. On 10/15/2025, the director acquired 568 shares of common stock in a transaction coded “A,” reflecting a grant in lieu of cash compensation for Board service for Q3‑25. The filing lists a price of $17.58.
Following this grant, the director’s beneficial ownership stands at 15,708 shares, held directly. This is a routine equity compensation event and does not indicate a public offering or company-level capital raise.
Precipio (PRPO): A company director reported acquiring 597 shares of common stock on October 15, 2025 at $17.58 per share. The shares were granted as equity in lieu of cash compensation for service on the Board for Q3-25.
Following the transaction, the reporting person beneficially owns 15,247 shares, held directly.
Precipio (PRPO) director Kathleen D. LaPorte reported acquiring 711 shares of common stock on October 15, 2025 at $17.58 per share. The grant was issued in lieu of cash compensation for service on the Board of Directors for Q3-25.
After this transaction, LaPorte directly owns 6,862 shares of Precipio common stock.
Leviticus Partners LP reports beneficial ownership of 130,000 shares of Precipio, Inc. common stock, representing 8.0% of the class. The filing states the shares are held with sole voting and dispositive power and were acquired and are held in the ordinary course of business, not for the purpose of changing control of the issuer. The filing is signed by Adam M Hutt as Managing Member and dated 09/22/2025. No group affiliations, subsidiaries, or additional arrangements are disclosed.
Kathleen LaPorte, a director of Precipio, Inc. (PRPO), reported the sale of 6,152 shares of the issuer's common stock on 09/08/2025 at a weighted average price of $20.06 per share. After the reported disposals, she beneficially owned 6,151 shares. The shares were originally granted to Ms. LaPorte on 04/15/2024 as consideration in lieu of cash for board service covering Q1 2023 through Q1 2024; that grant was approved by the board under Rule 16b-3 and is exempt from Section 16(b). The Form 4 is signed by Ms. LaPorte on 09/10/2025. The filing notes the shares were sold in multiple transactions at prices ranging from $20.00 to $20.50.
Form 144 notice for Precipio, Inc. (PRPO): A holder plans to sell 6,152 shares of Common stock through Morgan Stanley Smith Barney, with an aggregate market value of $123,384.51. The shares represent part of 1,619,584 shares outstanding and the proposed approximate sale date is 09/08/2025.
The shares were acquired on 04/15/2024 as board compensation and paid as compensation. The filer reports no sales in the past three months and certifies no undisclosed material information.
Precipio, Inc. filed a current report to disclose that it has terminated its Sales Agreement with A.G.P./Alliance Global Partners covering an at-the-market offering program for its common stock, effective September 2, 2025. After this termination, Precipio can no longer sell additional shares under that agreement.
From April 14, 2023 through September 2, 2025, the company sold 11,847 shares of common stock under the program, generating net proceeds of approximately $0.1 million after commissions and offering expenses. Precipio also issued a press release announcing the termination.
Precipio, Inc. furnished an updated investor presentation dated August 18, 2025, providing refreshed information for shareholders and other stakeholders. The presentation is available on the company’s investor relations website and replaces the prior version furnished on June 13, 2022.
The updated deck is included as Exhibit 99.1 to this current report, while the cover page interactive data file is identified as Exhibit 104. The company states that this information, including Exhibit 99.1, is being furnished rather than filed under the Securities Exchange Act of 1934, meaning it is not subject to Section 18 liabilities or automatically incorporated into other securities law filings.
Precipio, Inc. reported net sales of $5.65 million for the three months ended June 30, 2025, up from $4.44 million a year earlier, led by service revenue of $5.005 million versus $3.909 million. Gross profit for the quarter was $2.43 million compared with $1.72 million in the prior year. The company recorded net income of $74 thousand in the quarter versus a $1.22 million loss in Q2 2024; for the six months it reported a net loss of $810 thousand compared with a $3.30 million loss a year earlier. A material contributor to quarterly other income was a recorded Employee Retention Credit of approximately $789 thousand.
The balance sheet shows total assets of $18.82 million, cash of $1.13 million and an accumulated deficit of $103.3 million. Management discloses substantial doubt about the company’s ability to continue as a going concern for the next twelve months absent additional revenue or financing. Material items disclosed include purchase commitments of approximately $2.2 million, a CHC temporary funding balance of about $0.6 million to be repaid through January 2026, and customer concentration with one customer representing ~27% of net sales.